Please try another search
SpectraCure AB (publ) is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company specializes in cancer treatment technology. The Company develops photodynamic therapeutics based on photosensitive materials activated by laser. The Company's method is called interstitial photodynamic therapy (PDT). Interstitial PDT can be used for solid tumors in internal organs, such as cancer in the prostate, pancreas, and the head and neck area, among others. In addition, the Company offers software platform IDOSE for interstitial PDT treatment of solid cancer tumors in internal organs. With SpectraCure’s interstitial PDT method, the patient is given a photoactivated drug - photosensitizer in combination with laser light guided by a dose control system.
Name | Age | Since | Title |
---|---|---|---|
Jorgen Wennberg | 70 | 2022 | Independent Chairman of the Board |
Brian C. Wilson | - | - | KhayyamiScientific Advisors |
Colin Hopper | - | - | Scientific Advisor |
Tomas Kramar | 68 | 2022 | Independent Director |
Stephen Bown | - | - | Scientific Advisor |
Stephen M. Hahn | - | - | Scientific Advisor |
Homer Pien | 59 | 2021 | Independent Director |
Jesper Freij | 51 | 2022 | Independent Director |
Katarina Svanberg | 79 | 2003 | Independent Director |
Masoud Khayyami | 60 | 2021 | Interim CEO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review